However, some of these compounds, such as TX-1918, lack specificity and also inhibit other tyrosine kinases, including PKA, PKC, and Src-K, ultimately failing to demonstrate anti-cancer activity against several cancer cell lines [74]. The gene discussed is PRRT2; the disease is cancer.